Influenza Vaccine Solicitation: SPE2DP22R0004 and Amendment 0001.
The following bid opportunity has been posted: COVID Vaccine and Testing Services Contract #: CC-0150-22R View most recent and previous bid opportunities All Addenda will be issued on the website. Therefore, all interested respondents should check the website from now throughout the procurement opening. It is the sole responsibility of the respondent to be knowledgeable of all addenda related to this procurement.
The objective of this BAA is to support the pre-clinical development of novel vaccine adjuvants towards licensure for human use. For the purposes of this solicitation, vaccine adjuvants are defined using the U.S. Food and Drug Administration (FDA) definition: Vaccine adjuvants are agents added to, or used in conjunction with, vaccine antigens to augment or potentiate, and possibly target the specific immune response to the antigen.
To support the COVID-19 vaccination efforts, CDC worked with Deloitte to establish VAMS to facilitate mass vaccination scenarios and data collection/tracking of the COVID-19 vaccination. Now that Monkeypox (MPX) has been declared a national emergency, we must move quickly to apply enhancements to VAMS in order to support this emergency response.
Contract Opportunity Award Details General Information Classification Description Attachments/Links Contact Information History Award Notices Follow 6505--EMERGENCY HAEGARDA Vaccine Active Contract Opportunity Notice ID 36F79721D0249 Related Notice Contract Line Item Number All Department/Ind.
The contractor shall provide medical expert services and medical review /case managers for the National Vaccine Injury Compensation Program (VICP).
public transportation or who have barriers getting to a vaccination site; and residents who may not be comfortable accessing vaccine in traditional healthcare settings.
Contract Opportunity Award Details General Information Classification Description Attachments/Links Contact Information History Award Notices Follow COVID-19 Booster Vaccines Active Contract Opportunity Notice ID W58P0522C0017 Related Notice Department/Ind.